- Home
- ATOS vs LCUT Comparison
ATOS vs LCUT Comparison
Compare ATOS & LCUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- LCUT
- Stock Information
- Founded
- ATOS 2009
- LCUT 1945
- Country
- ATOS United States
- LCUT United States
- Employees
- ATOS N/A
- LCUT N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- LCUT Industrial Machinery/Components
- Sector
- ATOS Health Care
- LCUT Consumer Discretionary
- Exchange
- ATOS Nasdaq
- LCUT Nasdaq
- Market Cap
- ATOS 107.2M
- LCUT 90.8M
- IPO Year
- ATOS 2012
- LCUT 1991
- Fundamental
- Price
- ATOS $0.94
- LCUT $4.86
- Analyst Decision
- ATOS Strong Buy
- LCUT Buy
- Analyst Count
- ATOS 3
- LCUT 2
- Target Price
- ATOS $6.17
- LCUT $5.50
- AVG Volume (30 Days)
- ATOS 1.5M
- LCUT 153.5K
- Earning Date
- ATOS 08-11-2025
- LCUT 08-07-2025
- Dividend Yield
- ATOS N/A
- LCUT 3.56%
- EPS Growth
- ATOS N/A
- LCUT N/A
- EPS
- ATOS N/A
- LCUT N/A
- Revenue
- ATOS N/A
- LCUT $680,795,000.00
- Revenue This Year
- ATOS N/A
- LCUT $0.51
- Revenue Next Year
- ATOS N/A
- LCUT $1.90
- P/E Ratio
- ATOS N/A
- LCUT N/A
- Revenue Growth
- ATOS N/A
- LCUT N/A
- 52 Week Low
- ATOS $0.55
- LCUT $2.89
- 52 Week High
- ATOS $1.66
- LCUT $9.03
- Technical
- Relative Strength Index (RSI)
- ATOS 58.44
- LCUT 62.25
- Support Level
- ATOS $0.81
- LCUT $4.97
- Resistance Level
- ATOS $0.88
- LCUT $5.44
- Average True Range (ATR)
- ATOS 0.05
- LCUT 0.39
- MACD
- ATOS 0.01
- LCUT 0.08
- Stochastic Oscillator
- ATOS 84.07
- LCUT 79.12
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About LCUT Lifetime Brands Inc.
Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.